MeV <i>M</i> mRNA quantification in cells treated with an inhibitor of RNA polymerase III. by Pierre Khalfi (7868252)

Mesh partitioning results. by Hang Chen (23866)

GM Mask image count after preprocessing. by Muhammad Zubair (728141)

Architecture of Multi-EfficientNet. by Muhammad Zubair (728141)

Average Saliency Map Results. by Muhammad Zubair (728141)

Original dataset composition (Raw from ADNI). by Muhammad Zubair (728141)

Class-wise performance on the test set. by Muhammad Zubair (728141)

Details of Hyperparameters. by Muhammad Zubair (728141)

<i>N</i>. <i>bombycis</i> coated with BmVg in infected ovarioles. by Chunxia Wang (766713)

Ablation Study Result. by Muhammad Zubair (728141)

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

The infection of follicle and nurse cells by <i>N</i>. <i>bombycis</i>. by Chunxia Wang (766713)

Molecular docking and in vitro kinase assays. by Kafayat Yusuf (22104155)

DataSheet1_The Variants at APOA1 and APOA4 Contribute to the Susceptibility of Schizophrenia With Inhibiting mRNA Expression in Peripheral Blood Leukocytes.pdf by Yao Fan (1977274)

“…After the SZ patients received an average of 27.50 ± 9.90 days of antipsychotic treatment, the median (interquartile) of serum apoA1 in the SZ episode significantly increased from 1.03 (1.00.1.20) g/L to 1.08 (1.00.1.22) g/L with the p-value of 0.044.…”

Level of mucin secretion and water channel expression. by Ji Eun Kim (403026)

The interactions between BmVg domains and spore wall proteins (SWPs). by Chunxia Wang (766713)

Expression of mAChRs proteins and the key mediators within their downstream signaling pathway. by Ji Eun Kim (403026)

RNAi analysis on the role of BmVg in <i>N</i>. <i>bombycis</i> TOT. by Chunxia Wang (766713)